{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:39:53Z","timestamp":1789821593980,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"ALF"},{"DOI":"10.13039\/501100007949","name":"The Swedish Rheumatism Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001858","name":"Vinnova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derberg Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AFA"},{"name":"6th Framework Program of the European Union","award":["LSHM-CT-2006-037227"],"award-info":[{"award-number":["LSHM-CT-2006-037227"]}]},{"name":"European Union's Seventh Framework Programme","award":["115565"],"award-info":[{"award-number":["115565"]}]},{"DOI":"10.13039\/100013322","name":"EFPIA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.clim.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T14:14:17Z","timestamp":1461334457000},"page":"27-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms"],"prefix":"10.1016","volume":"166-167","author":[{"given":"Mizanur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Sing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Golabkesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Fiskesund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Jogestrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna G.","family":"Frosteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingi\u00e4ld","family":"Hafstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Frosteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2016.04.007_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frostegard","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clim.2016.04.007_bb0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1741-7015-11-117","article-title":"Immunity, atherosclerosis and cardiovascular disease","volume":"11","author":"Frostegard","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.clim.2016.04.007_bb0015","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in systemic lupus erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2016.04.007_bb0020","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.freeradbiomed.2010.08.001","article-title":"Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis","volume":"49","author":"Duryee","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.clim.2016.04.007_bb0025","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1073\/pnas.92.3.821","article-title":"Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis","volume":"92","author":"Palinski","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2016.04.007_bb0030","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1073\/pnas.77.4.2214","article-title":"Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages","volume":"77","author":"Fogelman","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2016.04.007_bb0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2009.08.013","article-title":"Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease","volume":"134","author":"Frostegard","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2016.04.007_bb0040","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/rheumatology\/ken120","article-title":"Natural antibodies against phosphorylcholine as potential protective factors in SLE","volume":"47","author":"Su","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2016.04.007_bb0045","doi-asserted-by":"crossref","first-page":"R214","DOI":"10.1186\/ar3193","article-title":"Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus","volume":"12","author":"Anania","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2016.04.007_bb0050","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1161\/CIRCRESAHA.113.301145","article-title":"B cells and humoral immunity in atherosclerosis","volume":"114","author":"Tsiantoulas","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.clim.2016.04.007_bb0055","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1161\/01.STR.28.11.2195","article-title":"A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness","volume":"28","author":"Wendelhag","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.clim.2016.04.007_bb0060","first-page":"676","article-title":"Carotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology","volume":"29","author":"Gray-Weale","year":"1988","journal-title":"J. Cardiovasc. Surg."},{"key":"10.1016\/j.clim.2016.04.007_bb0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.STR.26.1.34","article-title":"Carotid intima-media thickness and plaque in borderline hypertension","volume":"26","author":"Lemne","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.clim.2016.04.007_bb0070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.STR.29.2.439","article-title":"Potential of carotid ultrasonography in the diagnosis of coronary artery disease: a comparison with exercise test and variance ECG","volume":"29","author":"Nowak","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.clim.2016.04.007_bb0075","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1172\/JCI36800","article-title":"Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans","volume":"119","author":"Chou","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2016.04.007_bb0080","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1021\/tx970069t","article-title":"Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay","volume":"10","author":"Xu","year":"1997","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.clim.2016.04.007_bb0085","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2005.10.017","article-title":"Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension","volume":"188","author":"Su","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clim.2016.04.007_bb0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2009.05.003","article-title":"Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism","volume":"34","author":"de Faire","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2016.04.007_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.rinim.2012.01.001","article-title":"IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL","volume":"2","author":"Fiskesund","year":"2012","journal-title":"Res. Immunol."},{"key":"10.1016\/j.clim.2016.04.007_bb0100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am. J. Epidemiol."},{"issue":"663\u2013666","key":"10.1016\/j.clim.2016.04.007_bb0105","first-page":"A611","article-title":"Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome","volume":"87","author":"Roman","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.clim.2016.04.007_bb0110","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2016.04.007_bb0115","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1212\/01.wnl.0000314697.76580.cb","article-title":"Identifying vulnerable carotid plaques by noninvasive imaging","volume":"70","author":"Kwee","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2016.04.007_bb0120","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1161\/01.CIR.103.17.2171","article-title":"Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the Tromso study","volume":"103","author":"Mathiesen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2016.04.007_bb0125","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","article-title":"Autoantibody against oxidised LDL and progression of carotid atherosclerosis","volume":"339","author":"Salonen","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2016.04.007_bb0130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.ATV.15.4.441","article-title":"Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL","volume":"15","author":"Bergmark","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clim.2016.04.007_bb0135","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1001\/archinte.1994.00420220105012","article-title":"Antibody against oxidized low-density lipoprotein predicting myocardial infarction","volume":"154","author":"Puurunen","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.clim.2016.04.007_bb0140","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1161\/01.ATV.17.11.3159","article-title":"Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction","volume":"17","author":"Wu","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clim.2016.04.007_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.ATV.19.1.23","article-title":"Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease","volume":"19","author":"Lehtimaki","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clim.2016.04.007_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/01.HYP.33.1.53","article-title":"Autoantibodies to OxLDL are decreased in individuals with borderline hypertension","volume":"33","author":"Wu","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.clim.2016.04.007_bb0155","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.0000092891.55157.A7","article-title":"Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis","volume":"108","author":"Karvonen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2016.04.007_bb0160","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1515\/CCLM.2005.065","article-title":"Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis","volume":"43","author":"Rontu","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clim.2016.04.007_bb0165","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/eurheartj\/ehn336","article-title":"High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction","volume":"29","author":"Sjogren","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.clim.2016.04.007_bb0170","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/01.ATV.0000067935.02679.B0","article-title":"Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease","volume":"23","author":"Fredrikson","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clim.2016.04.007_bb0175","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1007\/s00125-009-1377-9","article-title":"Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes","volume":"52","author":"Fredrikson","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.clim.2016.04.007_bb0180","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0140-6736(93)91213-6","article-title":"Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus","volume":"341","author":"Vaarala","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2016.04.007_bb0185","doi-asserted-by":"crossref","first-page":"743","DOI":"10.5551\/jat.19281","article-title":"Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosis","volume":"20","author":"Lopes-Virella","year":"2013","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.clim.2016.04.007_bb0190","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1191\/0961203306lu2337oa","article-title":"Atherogenic oxidized low-density lipoprotein\/beta2-glycoprotein I (oxLDL\/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"15","author":"Matsuura","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2016.04.007_bb0195","first-page":"942","article-title":"Effect of biological therapy on levels of atheroprotective antibodies against phosphorylcholine and apolipoproteins in rheumatoid arthritis - a one year study","volume":"29","author":"Ajeganova","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2016.04.007_bb0200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1743-7075-4-7","article-title":"Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New Guinea","volume":"4","author":"Frostegard","year":"2007","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.clim.2016.04.007_bb0205","doi-asserted-by":"crossref","first-page":"e107440","DOI":"10.1371\/journal.pone.0107440","article-title":"Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease","volume":"9","author":"Anderson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2016.04.007_bb0210","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.clim.2012.01.002","article-title":"IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE","volume":"142","author":"Gronwall","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2016.04.007_bb0215","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/art.27442","article-title":"Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity","volume":"62","author":"Wang","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.04.007_bb0220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.20780","article-title":"Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations","volume":"52","author":"Frostegard","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.04.007_bb0225","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrrheum.2013.147","article-title":"Oxidative stress in the pathology and treatment of systemic lupus erythematosus","volume":"9","author":"Perl","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2016.04.007_bb0230","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.4049\/jimmunol.0804191","article-title":"IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells","volume":"182","author":"Chen","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.04.007_bb0235","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.cell.2010.02.014","article-title":"Autoimmunity and the clearance of dead cells","volume":"140","author":"Nagata","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.clim.2016.04.007_bb0240","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1172\/JCI1112","article-title":"Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta, PGE2, and PAF","volume":"101","author":"Fadok","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2016.04.007_bb0245","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCRESAHA.114.302355","article-title":"Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies","volume":"114","author":"Silvestre-Roig","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.clim.2016.04.007_bb0250","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coi.2015.03.004","article-title":"CD1d-dependent endogenous and exogenous lipid antigen presentation","volume":"34","author":"McEwen-Smith","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2016.04.007_bb0255","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.4049\/jimmunol.1303035","article-title":"Naturally occurring human phosphorylcholine antibodies are predominantly products of affinity-matured B cells in the adult","volume":"192","author":"Fiskesund","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.04.007_bb0260","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0008-8749(89)90137-8","article-title":"The potentiation of B lymphocyte responses through CD2\/LFA-3 interactions involving erythrocytes is IL2 independent","volume":"124","author":"Trifiletti","year":"1989","journal-title":"Cell. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616300663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616300663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T22:41:45Z","timestamp":1718491305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616300663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":52,"alternative-id":["S1521661616300663"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2016.04.007","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2016.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}